Prevalence of Chronic Obstructive Pulmonary Disease according to BTS, ERS, GOLD and ATS Criteria in Relation to Doctor’s Diagnosis, Symptoms, Age, Gender, and Smoking Habits
暂无分享,去创建一个
A. Lindberg | E. Rönmark | R. Lundgren | B. Lundbäck | L. Larsson | A. Jonsson | Ann-Christin Jonsson
[1] B. Celli,et al. Population impact of different definitions of airway obstruction , 2003, European Respiratory Journal.
[2] A. Gulsvik,et al. Sex differences in lung vulnerability to tobacco smoking , 2003, European Respiratory Journal.
[3] A. Gulsvik,et al. Epidemiological aspects and early detection of chronic obstructive airway diseases in the elderly , 2003, European Respiratory Journal.
[4] A. Iqbal,et al. Interpreting COPD prevalence estimates: what is the true burden of disease? , 2003, Chest.
[5] R. Buhl,et al. Newly Diagnosed Chronic Obstructive Pulmonary Disease , 2003, Respiration.
[6] K Larsson,et al. Not 15 but 50% of smokers develop COPD?--Report from the Obstructive Lung Disease in Northern Sweden Studies. , 2003, Respiratory medicine.
[7] R. Buhl,et al. Newly diagnosed chronic obstructive pulmonary disease. Clinical features and distribution of the novel stages of the Global Initiative for Obstructive Lung Disease. , 2003, Respiration; international review of thoracic diseases.
[8] A. Buist,et al. Risk of over-diagnosis of COPD in asymptomatic elderly never-smokers , 2002, European Respiratory Journal.
[9] M. Decramer,et al. Impact of COPD in North America and Europe in 2000: subjects' perspective of Confronting COPD International Survey , 2002, European Respiratory Journal.
[10] A. Buist. Guidelines for the management of chronic obstructive pulmonary disease. , 2002, Respiratory medicine.
[11] J. Vestbo,et al. Can GOLD Stage 0 provide information of prognostic value in chronic obstructive pulmonary disease? , 2002, American journal of respiratory and critical care medicine.
[12] D. Mannino. COPD: epidemiology, prevalence, morbidity and mortality, and disease heterogeneity. , 2002, Chest.
[13] R. Pauwels,et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: National Heart, Lung, and Blood Institute and World Health Organization Global Initiative for Chronic Obstructive Lung Disease (GOLD): executive summary. , 2001, Respiratory care.
[14] D. Tashkin,et al. Gender bias in the diagnosis of COPD. , 2001, Chest.
[15] A. Gulsvik,et al. The global burden and impact of chronic obstructive pulmonary disease worldwide. , 2001, Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace.
[16] B. Lundbäck,et al. Smoking, respiratory symptoms, and diseases : a comparative study between northern Sweden and northern Finland: report from the FinEsS study. , 2001, Chest.
[17] G. Viegi,et al. Epidemiology of Chronic Obstructive Pulmonary Disease (COPD) , 2001, Respiration.
[18] A. Lindberg,et al. Obstructive sleep apnoea syndrome is common in subjects with chronic bronchitis. Report from the Obstructive Lung Disease in Northern Sweden studies. , 2001, Respiration; international review of thoracic diseases.
[19] E. Silverman,et al. Gender-related differences in severe, early-onset chronic obstructive pulmonary disease. , 2000, American journal of respiratory and critical care medicine.
[20] M. Miravitlles,et al. Geographic variations in prevalence and underdiagnosis of COPD: results of the IBERPOC multicentre epidemiological study. , 2000, Chest.
[21] N. Pride,et al. Recent trends in physician diagnosed COPD in women and men in the UK , 2000, Thorax.
[22] T L Petty,et al. Obstructive lung disease and low lung function in adults in the United States: data from the National Health and Nutrition Examination Survey, 1988-1994. , 2000, Archives of internal medicine.
[23] P. Calverley,et al. COPD: early detection and intervention. , 2000, Chest.
[24] G. Viegi,et al. Prevalence of airways obstruction in a general population: European Respiratory Society vs American Thoracic Society definition. , 2000, Chest.
[25] M. Bottai,et al. Smooth reference equations for slow vital capacity and flow-volume curve indexes. , 2000, American journal of respiratory and critical care medicine.
[26] S. Hurd,et al. The impact of COPD on lung health worldwide: epidemiology and incidence. , 2000, Chest.
[27] W. Bailey,et al. Smoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease. The Lung Health Study. , 2000, American journal of respiratory and critical care medicine.
[28] B. Lundbäck,et al. Increasing prevalence of asthma but not of chronic bronchitis in Finland? Report from the FinEsS-Helsinki Study. , 1999, Respiratory medicine.
[29] D. Brooks,et al. Trends in the epidemiology of COPD in Canada, 1980 to 1995. COPD and Rehabilitation Committee of the Canadian Thoracic Society. , 1999, Chest.
[30] M. Miravitlles,et al. Estudio IBERPOC en España: prevalencia de síntomas respiratorios habituales y de limitación crónica al flujo aéreo , 1999 .
[31] M. Miravitlles,et al. [Epidemiological study of chronic obstructive pulmonary disease in Spain (IBERPOC): prevalence of chronic respiratory symptoms and airflow limitation]. , 1999, Archivos de bronconeumologia.
[32] C. van Weel,et al. Active detection of chronic obstructive pulmonary disease and asthma in the general population. Results and economic consequences of the DIMCA program. , 1998, American journal of respiratory and critical care medicine.
[33] BTS Guidelines for the Management of Chronic Obstructive Pulmonary Disease , 1997, Thorax.
[34] Denmark,et al. Gender difference in smoking effects on lung function and risk of hospitalization for COPD: results from a Danish longitudinal population study , 2002 .
[35] P. Sly,et al. Allergic respiratory disease: strategic targets for primary prevention during childhood. , 1997, Thorax.
[36] J. Vestbo,et al. Association of chronic mucus hypersecretion with FEV1 decline and chronic obstructive pulmonary disease morbidity. Copenhagen City Heart Study Group. , 1996, American journal of respiratory and critical care medicine.
[37] J C Yernault,et al. Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force. , 1995, The European respiratory journal.
[38] B. Make,et al. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. American Thoracic Society. , 1995, American journal of respiratory and critical care medicine.
[39] J. Schouten,et al. Smoking, changes in smoking habits, and rate of decline in FEV1: new insight into gender differences. , 1994, The European respiratory journal.
[40] B. Forsberg,et al. Epidemiology of respiratory symptoms, lung function and important determinants. Report from the Obstructive Lung Disease in Northern Sweden Project. , 1994, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[41] X. Xu,et al. Gender difference in smoking effects on adult pulmonary function. , 1994, The European respiratory journal.
[42] J E Cotes,et al. Lung volumes and forced ventilatory flows , 1993, European Respiratory Journal.
[43] J E Cotes,et al. Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. , 1993, The European respiratory journal. Supplement.
[44] D. Dockery,et al. Longitudinal lung function decline in subjects with respiratory symptoms. , 1992, The American review of respiratory disease.
[45] A. Gulsvik,et al. Prevalence of obstructive lung disease in a general population: relation to occupational title and exposure to some airborne agents. , 1991, Thorax.
[46] L. Nyström,et al. Obstructive lung disease in northern Sweden: respiratory symptoms assessed in a postal survey. , 1991, The European respiratory journal.
[47] N Poisson,et al. Validity and repeatability of the IUATLD (1984) Bronchial Symptoms Questionnaire: an international comparison. , 1989, The European respiratory journal.
[48] P. Schnohr,et al. Effects of smoking and changes in smoking habits on the decline of FEV1. , 1989, The European respiratory journal.
[49] E. Bleecker,et al. Evaluation of impairment/disability secondary to respiratory disorders. American Thoracic Society. , 2015, The American review of respiratory disease.
[50] ATS statement--Snowbird workshop on standardization of spirometry. , 1979, The American review of respiratory disease.
[51] M. Lebowitz,et al. Tucson epidemiologic study of obstructive lung diseases. I: Methodology and prevalence of disease. , 1975, American journal of epidemiology.
[52] E BERGLUND,et al. Spirometric studies in normal subjects. I. Forced expirograms in subjects between 7 and 70 years of age. , 2009, Acta medica Scandinavica.